HCV therapy and risk of liver cancer recurrence: who to treat?

被引：8
|
作者：
Colombo, Massimo [1 ,2 ,3 ]
Boccaccio, Vincenzo [1 ,2 ,3 ]
机构：
[1] Humanitas Hosp, Ctr Translat Res Hepatol, Rozzano, Italy
[2] Humanitas Clin & Res Ctr, Rozzano, Italy
[3] Humanitas Hosp, Dept Med, Rozzano, Italy
来源：
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY | 2018年 / 15卷 / 07期
关键词：
D O I：
10.1038/s41575-018-0018-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Recurrence of hepatocellular carcinoma after resection or ablation with curative intent is common and not prevented by direct-acting antiviral agent (DAA) therapy for hepatitis C. Owing to multiple methodological inconsistencies, available studies fail to answer whether DAA therapy anticipated risk of severe tumour recurrence: a prospective randomized study might serve the purpose. © 2018 Macmillan Publishers Ltd., part of Springer Nature.
引用
收藏
页码：392 / 394
页数：3
相关论文
共 50 条
  • [21] Host and donor risk factors before and after liver transplantation that impact HCV recurrence
    Berenguer, M
    LIVER TRANSPLANTATION, 2003, 9 (11) : S44 - S47
  • [22] Liver transplantation due to HCV - The problem of recurrence
    Patonai, A
    Nemes, B
    Sarvary, E
    Kobori, L
    Lengyel, G
    Weszelits, V
    Fehervari, I
    Perner, F
    Schaff, Z
    JOURNAL OF HEPATOLOGY, 2001, 34 : 35 - 35
  • [23] Immunosuppression and HCV recurrence after liver transplantation
    Samonakis, Dimitrios N.
    Germani, Giacomo
    Burroughs, Andrew K.
    JOURNAL OF HEPATOLOGY, 2012, 56 (04) : 973 - 983
  • [24] Immunogenetic factors, HCV genotypes, and HCV recurrence after liver transplantation
    Belli, LS
    Zavaglia, C
    Alberti, AB
    Rondinara, GF
    De Carlis, L
    Silini, E
    Poli, F
    Scalamogna, M
    Tinelli, G
    Forti, D
    Ideo, G
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 483 - 484
  • [25] WHO SHOULD TREAT CANCER
    不详
    LANCET, 1981, 2 (8248): : 674 - 674
  • [26] WHO SHOULD TREAT CANCER
    ROSE, M
    LANCET, 1981, 2 (8255): : 1115 - 1115
  • [27] WHO SHOULD TREAT CANCER
    WHITEHOUSE, JMA
    WILLIAMS, CJ
    BODKIN, PE
    MACDONALD, H
    BUCHANAN, R
    RYLE, RH
    HALL, V
    MALPAS, JS
    WRIGLEY, PSM
    LISTER, TA
    MCELWAIN, TJ
    SMYTHE, JF
    CALMAN, KC
    HABESHAW, T
    CROWTHER, D
    LANCET, 1981, 2 (8251): : 864 - 864
  • [28] WHO SHOULD TREAT CANCER
    SMITH, IE
    LANCET, 1981, 2 (8253): : 991 - 991
  • [29] WHO SHOULD TREAT CANCER
    TOBIAS, JS
    HARPER, PG
    TATTERSALL, MHN
    LANCET, 1981, 1 (8225): : 884 - 886
  • [30] WHO SHOULD TREAT CANCER
    PRICE, LA
    LANCET, 1981, 1 (8233): : 1318 - 1318
12345